Literature DB >> 1968427

Density and phenotype of tumour-associated mononuclear cells in colonic carcinomas determined by computer-assisted video image analysis.

M N Norazmi1, A W Hohmann, J M Skinner, L R Jarvis, J Bradley.   

Abstract

The density and phenotypes of tumour-associated mononuclear cells (TAMC) in tissue sections of colonic carcinomas was determined by the technique of video image analysis (VIA). This technique allowed an accurate and objective enumeration of both total mononuclear cells (MC) in H&E stained sections and individual types of cells as revealed by immunoperoxidase staining with monoclonal antibodies in frozen sections. This enumeration allowed reliable statistical analysis of the differences between sample groups. Using this technique it was found that the density of MC in histiologically normal tissue was significantly higher than in tumour tissue. Tumours from patients with the best prognosis (stage A) had significantly higher numbers of TAMC than stage B (P less than 0.02), C (P less than 0.002) and D (P less than 0.002) tumours. The differences in the density of TAMC between tumours obtained from stage B and C and that between C and D were not significant, whereas stage B had a significantly higher TAMC density than stage D tumours (P less than 0.05). Comparing tumour differentiation, well differentiated adenocarcinomas had a significantly higher (P less than 0.05) TAMC density than poorly differentiated tumours but not moderately differentiated tumours. Moderately and poorly differentiated adenocarcinomas did not differ significantly in the density of TAMC. In examining the phenotype of these cells, it was found that T lymphocytes formed the majority of the TAMC with the CD4+ subset predominating in 28 of 29 cases. Similarly, all sections of normal colon (taken at least 4 cm away from the tumour) had more CD4+ than CD8+ cells. The proportion of the total leucocyte population that was CD3+ was comparable in normal and tumour tissue. Generally, few macrophages were present in either tumour or normal tissues. B cells (CD21%) and subset of NK cells (CD57+) were not detected in the tumours. There were no significant differences in the proportion of leucocytes which were CD4+, CD8+ and CD14+ (macrophages) between the normal colon and the tumour tissues. The types of cells in the TAMC population did not differ with tumour stage or differentiation or with the density of the TAMC itself.

Entities:  

Mesh:

Year:  1990        PMID: 1968427      PMCID: PMC1385602     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  18 in total

1.  Assembly of actin filaments studied by laser light scattering and fluorescence photobleaching recovery.

Authors:  B R Ware; J W Klein
Journal:  Biophys J       Date:  1986-01       Impact factor: 4.033

2.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

3.  Heterogeneity of human B lymphocytes as revealed by monoclonal antibodies.

Authors:  J Brochier; J P Magaud; G Cordier; I Millet; J Marti; P A Bryon
Journal:  Ann Immunol (Paris)       Date:  1984 Nov-Dec

4.  Colonic carcinoma: a quantitative assessment of lymphocyte infiltration at the periphery of colonic tumors related to prognosis.

Authors:  A G Watt; A K House
Journal:  Cancer       Date:  1978-01       Impact factor: 6.860

5.  Elevation of infiltrating mononuclear phagocytes in human colorectal tumors.

Authors:  C Allen; N Hogg
Journal:  J Natl Cancer Inst       Date:  1987-03       Impact factor: 13.506

6.  Expression of histocompatibility antigens and characterization of mononuclear cell infiltrates in normal and neoplastic colorectal tissues of humans.

Authors:  H C Umpleby; D Heinemann; M O Symes; R C Williamson
Journal:  J Natl Cancer Inst       Date:  1985-06       Impact factor: 13.506

7.  Terminology and classification of colorectal adenocarcinoma: the Australian clinico-pathological staging system.

Authors:  N C Davis; R C Newland
Journal:  Aust N Z J Surg       Date:  1983-06

8.  Characterisation of breast cancer infiltrates using monoclonal antibodies to human leucocyte antigens.

Authors:  D J Rowe; P C Beverley
Journal:  Br J Cancer       Date:  1984-02       Impact factor: 7.640

9.  Antibodies to membrane structures that distinguish suppressor/cytotoxic and helper T lymphocyte subpopulations block the mixed leukocyte reaction in man.

Authors:  E G Engleman; C J Benike; E Glickman; R L Evans
Journal:  J Exp Med       Date:  1981-07-01       Impact factor: 14.307

10.  Expression of major histocompatibility antigens and leucocyte infiltration in benign and malignant human breast disease.

Authors:  H L Whitwell; H P Hughes; M Moore; A Ahmed
Journal:  Br J Cancer       Date:  1984-02       Impact factor: 7.640

View more
  6 in total

Review 1.  Delivery of cancer therapeutics to extracellular and intracellular targets: Determinants, barriers, challenges and opportunities.

Authors:  Jessie L-S Au; Bertrand Z Yeung; Michael G Wientjes; Ze Lu; M Guillaume Wientjes
Journal:  Adv Drug Deliv Rev       Date:  2015-12-11       Impact factor: 15.470

2.  Proliferation of T-cell subsets that contact tumour cells in colorectal cancer.

Authors:  S J C Golby; C Chinyama; J Spencer
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

3.  T cell receptor-zeta and granzyme B expression in mononuclear cell infiltrates in normal colon mucosa and colon carcinoma.

Authors:  W M Mulder; E Bloemena; M J Stukart; J A Kummer; J Wagstaff; R J Scheper
Journal:  Gut       Date:  1997-01       Impact factor: 23.059

4.  Improving evaluation of the distribution and density of immunostained cells in breast cancer using computerized video image analysis.

Authors:  Brendon J Coventry; Michael J Weightman; John M Skinner; John Bradley
Journal:  Cancer Manag Res       Date:  2011-04-18       Impact factor: 3.989

Review 5.  Biological treatment for liver tumor and new potential biomarkers.

Authors:  Maurizio Chiriva-Internati; Fabio Grizzi; Mitchell S Wachtel; Marjorie Jenkins; Raffaele Ferrari; Everardo Cobos; Eldo E Frezza
Journal:  Dig Dis Sci       Date:  2007-08-22       Impact factor: 3.199

6.  Colorectal cancer-infiltrating T lymphocytes display a distinct chemokine receptor expression profile.

Authors:  Ann-Britt Löfroos; Mohammad Kadivar; Sabina Resic Lindehammer; Jan Marsal
Journal:  Eur J Med Res       Date:  2017-10-11       Impact factor: 2.175

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.